Patent · US Active

EGFR-homing double-stranded RNA vector for systemic cancer treatment

US9006406B2 · kind B2 · utility

5Cited by

0References

2Claims

0Family size

Assignee

Alexander Levitzki · IL

Inventors

Alexander Levitzki · Melrose, US
Alexei Shir · Jerusalem, IL

Key dates

Filing date	Dec 22, 2009
Grant date	Apr 14, 2015
Priority date	—
Expiry date	Mar 24, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/17
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An epidermal growth factor receptor (EGFR)-homing vector comprising a double-stranded RNA (dsRNA) molecule with an EGFR-binding peptide or polypeptide, is disclosed for use in combination with immune cells for treatment of cancer overexpressing EGFR.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.